i said earlier this year that monotherapy did nothing for me, and at a higher dose it did something
📉16
#cagrilintide 2026-03-31
Tuesday19 messages4 participantstimes are UTC
Highlights from this day
- flint_fills — i said earlier this year that monotherapy did nothing for me, and at a higher dose it did something 19:39
- karl_fischer — if youre used to GLP-1 titration steps this feels absurdly cautious and i still do it that way 20:21
- flint_fills — stopped for 24 months and the fullness went within a fortnight of the last dose 20:56
right so the reason nausea reads differently is timing, mine arrived on the second day rather than the first
[edited]Inter-lab diff for lot B-0329: 97.4% vs 99.2%. Within expected range.
if youre used to GLP-1 titration steps this feels absurdly cautious and i still do it that way
🤝2🙏17
cant separate them
i keep the two on separate days so if something goes wrong i have a chance of knowing which
amylin not glp-1
held at 10 for 8 months on monotherapy before i touched it again
nobody should copy my schedule, im describing it because people asked what a slow ramp looks like
i titrated over twice as many weeks as i did on semaglutide and that was right for me, i think
€72 for a 15 vial and it lasts me longer than the GLP-1 does at my doses
Batch lookup G-0641: 7 independent reports on file, earliest 2026-01-14.
stopped for 24 months and the fullness went within a fortnight of the last dose
💀7🎉1
went slower because the first step gave me two rough days and i took that as information
coming back to this amylin is about slowed gastric emptying and satiety signalling, thats the short version and im no pharmacologist
30 in 2ml gives 2mg/ml which is what i use, purely because the units come out round
follow up its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake
did the nausea feel different to you or just less
noticed something around week 13 on monotherapy, well after i had given up expecting to